FDA-approved autologous cell harvesting for burns and full-thickness skin defects · from a small sample of the patient's own skin.



In October 2002, three bombs tore through Kuta, Bali. 202 people were killed; 88 were Australian. Survivors flown home carried burns that traditional grafts could not cover in time.
Dr. Fiona Wood AM, plastic surgeon and Director of the Burns Service of Western Australia, led the team that treated them, using her spray-on skin technology, ReCell®.

She was named 2005 Australian of the Year for the work.
Two decades later, that same technology is AVITA Medical's flagship product.
Source · Auspire (Australia Day Council of WA), 21 Oct 2022 · Dr. Fiona Wood reflects on Bali bombings 20 years onFDA-approved autologous cell harvesting for burns and full-thickness skin defects · from a small sample of the patient's own skin.
Transparent wound dressing for surgical, trauma and burn wound management.
Bioabsorbable collagen matrix for full-thickness wound reconstruction.
AVITA moved from a limited contract-manufacturing model to a U.S.-owned operation · reducing scale constraints and taking control of supply.

AVITA relies on external manufacturing partners · limiting scale, control and margin.
U.S. market unlocked. AVITA acquires a manufacturing facility in Ventura, CA to bring production in-house.
Corporate re-domiciles and re-centers around the U.S. · Valencia HQ, Ventura manufacturing, Irvine admin & research.
United StatesEuropean UnionJapanAustraliaNew Zealand






